InvestorsHub Logo
Followers 157
Posts 10492
Boards Moderated 3
Alias Born 10/14/2001

Re: BioSpecialist post# 241

Saturday, 03/29/2014 7:04:05 AM

Saturday, March 29, 2014 7:04:05 AM

Post# of 457
$CONX Realistic Target are $1.50-2.00 within 12 months !!!

Ebola ‘a regional threat’ [Ebola Virus Spreading Quickly Across]
http://article.wn.com/view/2014/03/28/Ebola_a_regional_threat/

“This outbreak clearly demonstrates that Ebola, though rare, is still a major public health problem,” said Douglass Simpson, Corgenix President and CEO. “When it does occur, it is deadly, and getting test results back quickly is the key to diagnosing and treating patients and saving lives.”

Current Ebola testing requires special biohazard handling, and samples are often sent out of West Africa for processing. This can result in delays of up to several days before diagnosis can be confirmed and treatment started. The Corgenix ReLASV test is a rapid, highly accurate, 15-minute test that detects Lassa virus antigen in blood, leading to early acute-stage treatment, which is key to survival. ReLASV is currently being used on-site at KGH in Sierra Leone for Lassa fever testing and diagnosis.

“We are expanding our rapid testing platform to Ebola with the intention of extending screening to patients using these advanced diagnostics,” said Simpson. “Due to the added risk to the population and health care workers, it will be important that health officials have the ability to screen not only for Lassa, but for Ebola, with a rapid test capable of being run in field hospitals in a format that works throughout West Africa.”



CONX & AXXE best short and mid term plays both will be trading over $1 in the coming weeks .GL


Member mark for you buddy !
Best Regards,
sam

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.